T1	Participants 80 118	age related macular degeneration (AMD)
T2	Participants 258 296	age-related macular degeneration (AMD)
T3	Participants 542 651	Patients that had nonexudative age-related macular degeneration (AMD) and certain hemorheologic abnormalities
T4	Participants 883 895	216 patients
T5	Participants 1620 1709	There appeared to be patients entered into the study that did not meet inclusion criteria
